P/E ratio for SurgePays (SURG)

P/E ratio history for SurgePays from 2018 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
STAAR Surgical STAA	55.0	2,925.86%	🇺🇸 USA
Integra LifeSciences IART	20.4	1,021.58%	🇺🇸 USA
Cooper Companies COO	17.1	840.85%	🇺🇸 USA
Stryker Corporation SYK	57.3	3,057.37%	🇺🇸 USA
Johnson & Johnson JNJ	10.3	467.90%	🇺🇸 USA
Novartis NVS	26.2	1,345.34%	🇨🇭 Switzerland
CONMED CNMD	37.4	1,957.63%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.